Rayonier Advanced Materials (RYAM) came out with a quarterly loss of $0.43 per share versus the Zacks Consensus Estimate of a loss of $0.2. This compares to earnings of $0.19 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -115.00%. A quarter ago, it was expected that this maker of cellulose products would post a loss of $0.14 per share when it actually produced a loss of $0.49, delivering a surprise of -250%.Over the last fou ...

RYAM Reports Second Quarter 2025 Results Long-Term Strategic Direction and Value Creation Remain Firmly Intact JACKSONVILLE, Fla., August 5, 2025 - Rayonier Advanced Materials Inc. (NYSE:RYAM) (the "Company") today reported results for its second quarter ended June 28, 2025. "Our second quarter results were impacted by a series of extraordinary and largely non-recurring challenges, including tariff volatility, operational disruptions and significant non-cash charges," said De Lyle Bloomquist, President and ...

Summary of ProPetro Conference Call Company Overview - **Company**: ProPetro Holding Corp - **Industry**: Oilfield Services, specifically focused on the Permian Basin - **Headquarters**: Midland, Texas - **Ticker Symbol**: PUMP Key Points and Arguments 1. **Strong Financial Performance**: ProPetro reported a revenue of $73 million and EBITDA of $22 million in Q1, with a strong free cash flow of $22 million for the quarter, which could exceed $50 million when excluding capital investments in new ventures [3][4][7] 2. **Investment in Technology**: The company has invested over $1 billion since 2022 to refresh assets and diversify service offerings, including the launch of Pro Power, a power generation startup [1][2] 3. **Long-term Contracts**: Over 50% of the current fleet operates under long-term agreements, including a recent ten-year contract for Pro Power, indicating a stable revenue stream [3][25] 4. **Transition to Lower Emission Equipment**: ProPetro is innovating to meet the demand for lower emission solutions by transitioning to gas-burning and electric fleets, which are more efficient and cost-effective for clients [6][56] 5. **Market Position**: The company maintains a strong market presence in the Permian Basin, which accounts for over 40% of U.S. oil production, and is exploring opportunities in other basins through M&A [10][11] 6. **M&A Strategy**: Recent acquisitions have been capital-light and accretive, enhancing operational leverage and free cash flow generation [14][15] 7. **Electric Equipment Deployment**: ProPetro has deployed electric equipment that has shown high efficiency and low maintenance costs, with plans to expand this fleet [23][24] 8. **Pro Power Growth Potential**: The Pro Power initiative is expected to capture significant market share in the power generation sector, with projected load growth of about 4 gigawatts in the Permian Basin over the next five to seven years [26][30] 9. **Competitive Advantage**: The company has established strong relationships with equipment manufacturers, ensuring timely access to necessary technology and equipment [51][49] 10. **Capital Allocation Strategy**: ProPetro has pivoted from share repurchases to investing in Pro Power, indicating a focus on long-term growth and sustainability [17][54] Additional Important Insights - **Market Dynamics**: The oilfield service space is healthier than in previous cycles, with improved capital discipline among peers and customers [9][18] - **Future Opportunities**: ProPetro is exploring data center power supply opportunities, leveraging existing relationships in the oil and gas sector [40][42] - **Environmental Considerations**: The shift to electric and gas-burning equipment is not solely driven by regulations but also by cost efficiencies for operators [55][56] - **Long-term Contracts**: The company is focusing on securing long-term contracts to ensure stable revenue and mitigate market volatility [34][35] This summary encapsulates the key points discussed during the ProPetro conference call, highlighting the company's strategic direction, financial performance, and market opportunities.

Company Overview - RYAM produces natural cellulose fibers for diverse end-use products and operates four production facilities across the U S, Canada, and France[14] - The company's strategic investments focus on Biomaterials growth and operational efficiencies[14] Financial Performance and Targets - The company anticipates revenue between $15 billion and $16 billion for 2025[20] - The company projects EBITDA between $175 million and $185 million for 2025[22] - The company aims for $325 million in run-rate EBITDA by 2027, driven by a stable core business and biomaterials growth[41] Strategic Initiatives and Risks - The company is reducing commodity exposure, with non-Fluff commodities decreasing from 15% of sales in 2023 to 5% in 2024, and an estimated impact reduction from approximately -$60 million in 2023 to approximately -$5 million in 2025[29] - The company is investing in strategic capital expenditures with a minimum 30% ROE and less than 2-year payback, including $141 million in Biomaterials and $33 million in Cellulose Specialties projects[33] Tariff Impact and Mitigation - The company faces tariff exposure in Cellulose Specialties (China: ~$160 million, EU: ~$115 million), Cellulose Commodities (China: ~$85 million, EU: ~$30 million), and Paperboard (~$175 million)[69] - The company is implementing mitigation strategies such as customer advocacy, market diversification, and operational adjustments to address tariff impacts[64, 68]

Rayonier Advanced Materials (RYAM) Update Summary Company Overview - Rayonier Advanced Materials (RYAM) is undergoing a transformation to separate its high-margin cellulose specialties (CS) business from lower-margin commodity exposure, while also highlighting its emerging biomaterials platform [1][2] Key Points and Arguments - **New Segment Reporting**: The company has updated its reporting structure to better reflect its current operations and to provide clearer visibility into its high-margin segments [1][2][10] - **Long-term Strategy**: Confidence in the long-term strategy and value creation plan remains unchanged despite recent operational challenges and market noise [2][4] - **Operational Challenges**: The recent quarter faced challenges including higher input costs, operational difficulties, and weather-related disruptions, but these do not alter the company's long-term fundamentals [3][4] - **Price Increases**: The CS business outlook is strong, with a mid-single-digit price increase secured for 2025 while maintaining market share [5][16] - **Market Position**: RYAM holds approximately 40% market share in cellulose specialties, producing both hardwoods and softwoods, which provides a competitive advantage [6] - **Maintenance and Efficiency**: Major maintenance shutdowns have been completed, and the company is focusing on efficiency gains and strategic capital deployment to enhance margins [6][8] - **Biomaterials Growth**: The biomaterials platform is positioned to benefit from growing demand for renewable materials, with investments supported by secured green financing [7][8][23] - **EBITDA Targets**: The company aims for an annual EBITDA target of $325 million, with a focus on execution of its strategy [8] Financial Performance - **EBITDA Margins**: The CS segment reported a 23% EBITDA margin, while the emerging biomaterials segment achieved a 29% EBITDA margin, indicating strong profitability in these areas [11][23] - **Sales and Guidance**: For 2025, guidance for the CS business is set between $237 million to $245 million, with earnings expected to be back-end loaded due to operational recovery [18][25] - **Overall Guidance**: The overall EBITDA guidance has been adjusted to $175 million to $185 million, reflecting challenges in non-core segments and tariff impacts [25] Competitive Landscape - **Cellulose Specialties**: This segment is crucial, accounting for 56% of sales volumes, and competes on performance with a long qualification process for products [16][17] - **Commodity Products**: The company is minimizing exposure to lower-margin commodity products, focusing instead on higher-value offerings [20][21] Strategic Initiatives - **Joint Venture with BioNova**: The creation of BioNova aims to accelerate growth in biomaterials while avoiding shareholder dilution, leveraging project-specific funding [29][30] - **Capital Allocation**: RYAM plans to generate $5 million to $15 million in free cash flow for strategic investments, with a focus on maintaining a healthy balance sheet [37][40] Macro Trends and Risks - **Tailwinds**: Strong demand for sustainable materials and favorable green funding environments are expected to benefit RYAM's operations [47] - **Risks**: Trade policy uncertainty, inflation in raw materials, and logistics challenges are potential risks that could impact performance [48][49] Conclusion - RYAM is positioned for growth through strategic focus on high-margin segments and investments in biomaterials, while navigating operational challenges and market dynamics. The company remains committed to executing its long-term strategy and achieving its financial targets [8][51]

Financial Performance - In Q1 2025, the company reported an 8% decline in revenue and a 67% reduction in adjusted EBITDA compared to Q1 2024, which was below expectations [6][10] - The financial foundation remains solid with liquidity of $272 million and a net secured debt reduction to $624 million, resulting in a net secured leverage ratio of 2.9 times covenant EBITDA [10][16] Business Segment Performance - In the Cellular Specialty segment, quarterly net sales decreased by $5 million to $201 million, with operating income down $7 million to $31 million due to higher input costs and operational challenges [11][12] - The cellulose commodities segment saw net sales decline by $19 million to $75 million, with operating results improving by $6 million year-over-year to a loss of $13 million [12][13] - The new biomaterials segment maintained steady net sales at $7 million, with operating income flat at $2 million [13] - Paperboard segment net sales decreased by $4 million to $49 million, resulting in an operating loss of $2 million, down $10 million [14] - High yield pulp segment net sales declined by $3 million to $31 million, with operating losses increasing to $7 million due to lower market pricing and reduced volumes [15][29] Market Dynamics - The company faces significant challenges from tariffs, particularly a 25% tariff imposed by China on US-sourced cellulose commodities, affecting approximately $85 million of annual revenue [9][10] - The company is actively mitigating tariff risks through customer advocacy, market diversification, and operational adjustments [18][21] Strategic Direction - The company plans to focus on tariff mitigation actions, increase production of non-fluff commodities, and pursue high-return, low-risk strategic investments [19][30] - The biomaterials growth strategy remains intact, with key projects expected to advance and final investment decisions anticipated in the second half of the year [20][30] Management Commentary - Management acknowledged the challenging start to the year and ongoing uncertainties in the global market but expressed confidence in the resilience of the core business [81][82] - The company has lowered its full-year guidance for adjusted EBITDA to a range of $175 million to $185 million, reflecting the impact of tariffs and production issues [10][22] Other Important Information - The company expects unfavorable foreign exchange adjustments of $5 million due to a weakened US dollar against the Canadian dollar and euro [23] - Maintenance capital expenditure remains at $85 million, primarily driven by extended planned maintenance outages [24] Q&A Session Question: Conditions in the fluff pulp market with China's retaliatory tariffs - Management indicated that some Chinese customers continue to place orders but do not expect this to last long due to tariff costs, leading to a pivot towards non-tariff markets like India and Africa [35][36] Question: Evolution of volumes following Liberation Day - Management noted that volumes were lower than expected due to pre-orders and concerns about tariffs, with a significant drop in orders during April, but a resumption of orders was expected in May [40][44] Question: Evolution of paperboard guidance for 2025 - Management confirmed that the risk of tariffs on paperboard did not materialize, and pricing is expected to decrease by approximately 5% due to increased supply from new capacity [47][50]

Financial Performance and Key Metrics - In Q1 2025, the company reported an 8% decline in revenue and a 67% reduction in adjusted EBITDA compared to Q1 2024, which was described as disappointing [5][9] - The company ended the quarter with liquidity of $272 million and a net secured debt reduction of $624 million, resulting in a net secured leverage ratio of 2.9 times covenant EBITDA [8][14] Business Segment Performance - In the Cellular Specialty segment, quarterly net sales decreased by $5 million to $201 million, with a 2% sales price increase offset by a 2% decline in sales volume [9][10] - The cellulose commodities segment saw net sales decline by $19 million to $75 million, with operating results improving by $6 million year over year to a loss of $13 million [10][11] - The new biomaterials segment maintained steady net sales at $7 million, with operating income flat at $2 million [11] - Paperboard segment net sales decreased by $4 million to $49 million, reflecting a 4% decrease in sales prices and a 3% decline in sales volumes [12] - High yield pulp segment net sales declined by $3 million to $31 million, with operating losses increasing to $7 million [12][13] Market Dynamics - The company faces significant challenges from tariffs, particularly a 25% tariff imposed by China on US-sourced cellulose commodities, affecting approximately $85 million of annual revenue [7][9] - The company is actively mitigating tariff risks through customer advocacy, market diversification, and operational adjustments [17][20] Strategic Direction and Industry Competition - The company plans to focus on tariff mitigation actions and will likely pause some strategic initiatives, including debt reduction, due to cash flow uncertainties [18][29] - The biomaterials growth strategy remains intact, with expectations for continued investment in US-centric projects [18][29] Management Commentary on Operating Environment and Future Outlook - Management acknowledged the challenging start to 2025 and ongoing uncertainties in the global market but expressed confidence in the resilience of the core business [74][75] - Adjusted EBITDA guidance for 2025 has been lowered to a range of $175 million to $185 million, reflecting various challenges including tariff impacts and production issues [21][22] Other Important Information - The company expects to see a modest improvement in paperboard volumes due to better market access within North America, although prices remain under pressure [27][50] - Corporate costs are projected to increase year over year, primarily due to a non-cash environmental reserve charge and foreign exchange headwinds [28] Q&A Session Summary Question: Conditions in the fluff pulp market with China's retaliatory tariffs - Management indicated that some Chinese customers continue to place orders but do not expect to absorb tariffs long-term, leading to a pivot towards non-tariff markets like India and Africa [31][34] Question: Evolution of volumes following Liberation Day - Management noted that volumes were lower than expected due to pre-orders and that orders resumed in May after a pause in April, with expectations for normalization by Q3 [39][43] Question: Evolution of paperboard guidance for 2025 - Management confirmed that the risk of tariffs on paperboard has reversed, and pricing is expected to decrease by approximately 5% due to increased supply [45][50]

Group 1 - Rayonier Advanced Materials reported a quarterly loss of $0.49 per share, significantly worse than the Zacks Consensus Estimate of a loss of $0.14, marking an earnings surprise of -250% [1] - The company posted revenues of $356 million for the quarter ended March 2025, missing the Zacks Consensus Estimate by 8.39%, and down from $388 million in the same quarter last year [2] - Rayonier Advanced Materials shares have declined approximately 48.4% year-to-date, contrasting with the S&P 500's decline of -3.9% [3] Group 2 - The current consensus EPS estimate for the upcoming quarter is $0.01 on revenues of $420.1 million, and for the current fiscal year, it is $0.11 on revenues of $1.67 billion [7] - The Paper and Related Products industry, to which Rayonier Advanced Materials belongs, is currently ranked in the top 20% of over 250 Zacks industries, indicating a favorable outlook compared to lower-ranked industries [8]

First Quarter 2025 Financial Presentation Materials May 7, 2025 Safe Harbor Forward-Looking Statements Certain statements in this document regarding anticipated financial, business, legal or other outcomes, including business and market conditions, outlook and other similar statements relating to future events, developments or financial or operational performance or results, are "forward-looking statements" made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 a ...

Financial Performance - Net sales for Q1 2025 were $356 million, a decrease of $32 million or 8.2% from the prior year quarter[5]. - The company reported a net loss of $32 million, or $(0.49) per diluted share, compared to a net loss of $2 million, or $(0.02) per diluted share, in the prior year quarter[6]. - Adjusted EBITDA for Q1 2025 was $17 million, down $35 million from the prior year quarter, including a $12 million non-cash environmental charge[5]. - Overall EBITDA is projected to be $8 million to $10 million for the full year 2025[37]. - EBITDA is expected to approximate negative $5 million for the full year 2025, subject to fluctuations in tariff rates[35]. - The company reported a net loss of $32 million for the three months ended March 29, 2025, translating to a loss of $0.49 per diluted share[73]. - Adjusted net loss for the same period was $32 million, or $0.49 per diluted share, compared to an adjusted net loss of $6 million, or $0.10 per diluted share, for the previous quarter[73]. Cash Flow and Debt - Cash provided by operating activities for Q1 2025 was $40 million, with Adjusted Free Cash Flow generation of $10 million[5][26]. - Cash provided by operating activities increased to $40 million in Q1 2025, up from $12 million in Q1 2024[68]. - The company anticipates cash provided by operating activities to be between $90 million and $100 million for 2025[69]. - Total debt as of March 29, 2025, was $736 million, with a net secured debt of $624 million and a net secured leverage ratio of 2.9 times[5][28]. - Total debt increased to $736 million as of March 29, 2025, from $730 million at the end of 2024[71]. - Long-term debt remained stable at $707 million as of March 29, 2025, compared to $706 million at the end of 2024[71]. Sales and Pricing - Cellulose Specialties net sales decreased by $5 million, or 2%, compared to the prior year quarter, driven by a decrease in sales volumes[8]. - Average sales prices for Cellulose Specialties in 2025 are expected to increase by a mid single-digit percentage compared to 2024[32]. - Average sales price for Cellulose Specialties rose to $1,750 per metric ton, a 1.0% increase from $1,732 in the previous quarter[63]. - The average sales price for High-Yield Pulp decreased to $518 per metric ton, down from $523 in the previous quarter[63]. - Paperboard volumes are expected to increase in 2025, but prices are projected to decline year over year[39]. - High-Yield Pulp prices and volumes are expected to decline in 2025, with overall EBITDA approximating negative $20 million[41]. Future Projections and Strategies - The company projects 2025 Adjusted EBITDA to range between $175 million and $185 million, reflecting impacts from tariffs and operational challenges[4][29]. - Adjusted EBITDA for continuing operations is projected to be between $175 million and $185 million for 2025[66]. - Corporate costs are expected to approximate $70 million for the full year 2025, influenced by $12 million non-cash environmental reserves charges[42]. - The Company secured green capital of €67 million in Q4 2024 to advance its biomaterials strategy, aiming for over $70 million of EBITDA from this business[36]. - The company is exploring the potential sale of its Paperboard and High-Yield Pulp assets, but the process is currently on hold due to global trade uncertainty[30]. - The bioethanol facility in France has been operational since Q1 2024, and the Company is pursuing a similar facility in Fernandina Beach, Florida[38]. - The Company is evaluating investments in new facilities in Georgia and is working on permitting and engineering ahead of final investment decisions later this year[38]. Conference and Reporting - The Company will host a conference call on May 7, 2025, to discuss these results[43]. - Total assets decreased slightly to $2,118 million as of March 29, 2025, from $2,130 million at the end of 2024[58]. - The company incurred indefinite suspension charges of $3 million, impacting the previous quarter's results[73]. - Debt refinancing charges amounted to $10 million in the previous quarter, contributing to the adjusted net loss[73]. - The tax effect of adjustments was a reduction of $3 million in the previous quarter, affecting the overall financial performance[73].